Increase of regulatory T cells in the peripheral blood of cancer patients AM Wolf, D Wolf, M Steurer, G Gastl, E Gunsilius, B Grubeck-Loebenstein Clinical cancer research 9 (2), 606-612, 2003 | 1304 | 2003 |
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes AM Wolf, D Wolf, H Rumpold, B Enrich, H Tilg Biochemical and biophysical research communications 323 (2), 630-635, 2004 | 1068 | 2004 |
The expression of the regulatory T cell–specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer D Wolf, AM Wolf, H Rumpold, H Fiegl, AG Zeimet, E Muller-Holzner, ... Clinical cancer research 11 (23), 8326-8331, 2005 | 651 | 2005 |
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 589 | 2015 |
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells M Paolino, A Choidas, S Wallner, B Pranjic, I Uribesalgo, S Loeser, ... Nature 507 (7493), 508-512, 2014 | 466 | 2014 |
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation … A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ... Journal of Clinical Oncology 38 (26), 2993-3002, 2020 | 404 | 2020 |
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo A Heine, SAE Held, SN Daecke, S Wallner, SP Yajnanarayana, C Kurts, ... Blood, The Journal of the American Society of Hematology 122 (7), 1192-1202, 2013 | 370 | 2013 |
Importance of Kupffer cells for T-cell-dependent liver injury in mice J Schümann, D Wolf, A Pahl, K Brune, T Papadopoulos, N van Rooijen, ... The American journal of pathology 157 (5), 1671-1683, 2000 | 368 | 2000 |
Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy K Eller, A Kirsch, AM Wolf, S Sopper, A Tagwerker, U Stanzl, D Wolf, ... Diabetes 60 (11), 2954-2962, 2011 | 351 | 2011 |
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors P Valent, E Hadzijusufovic, GH Schernthaner, D Wolf, D Rea, P le Coutre Blood, The Journal of the American Society of Hematology 125 (6), 901-906, 2015 | 301 | 2015 |
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD RF Schlenk, D Weber, W Fiedler, HR Salih, G Wulf, H Salwender, ... Blood, The Journal of the American Society of Hematology 133 (8), 840-851, 2019 | 289 | 2019 |
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2 … U Platzbecker, JM Middeke, K Sockel, R Herbst, D Wolf, CD Baldus, ... The Lancet Oncology 19 (12), 1668-1679, 2018 | 287 | 2018 |
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study H Gisslinger, C Klade, P Georgiev, D Krochmalczyk, ... The Lancet Haematology 7 (3), e196-e208, 2020 | 262 | 2020 |
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 259 | 2018 |
CD4+ CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice D Wolf, K Hochegger, AM Wolf, HF Rumpold, G Gastl, H Tilg, G Mayer, ... Journal of the American Society of Nephrology 16 (5), 1360-1370, 2005 | 227 | 2005 |
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats I Theurl, A Schroll, T Sonnweber, M Nairz, M Theurl, W Willenbacher, ... Blood, The Journal of the American Society of Hematology 118 (18), 4977-4984, 2011 | 223 | 2011 |
Iron deficiency or anemia of inflammation? Differential diagnosis and mechanisms of anemia of inflammation M Nairz, I Theurl, D Wolf, G Weiss Wiener Medizinische Wochenschrift 166 (13), 411-423, 2016 | 218 | 2016 |
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions—a … T Schroeder, E Rachlis, G Bug, M Stelljes, S Klein, NK Steckel, D Wolf, ... Biology of Blood and Marrow Transplantation 21 (4), 653-660, 2015 | 212 | 2015 |
Overexpression of indoleamine 2, 3-dioxygenase in human inflammatory bowel disease AM Wolf, D Wolf, H Rumpold, AR Moschen, A Kaser, P Obrist, D Fuchs, ... Clinical immunology 113 (1), 47-55, 2004 | 199 | 2004 |
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression K Eller, D Wolf, JM Huber, M Metz, G Mayer, ANJ McKenzie, M Maurer, ... The Journal of Immunology 186 (1), 83-91, 2011 | 194 | 2011 |